Background: Epithelial ovarian cancer (EOC) is the most malignant gynecological tumor in women. This study aimed to construct and compare radiomics-clinical nomograms based on MR images in EOC prognosis prediction.

Methods: A total of 186 patients with pathologically proven EOC were enrolled and randomly divided into a training cohort (n = 130) and a validation cohort (n = 56). Clinical characteristics of each patient were retrieved from the hospital information system. A total of 1116 radiomics features were extracted from tumor body on T2-weighted imaging (T2WI), T1-weighted imaging (T1WI), diffusion weighted imaging (DWI) and contrast-enhanced T1-weighted imaging (CE-T1WI). Paired sequence signatures were constructed, selected and trained to build a prognosis prediction model. Radiomic-clinical nomogram was constructed based on multivariate logistic regression analysis with radiomics score and clinical features. The predictive performance was evaluated by receiver operating characteristic curve (ROC) analysis, decision curve analysis (DCA) and calibration curve.

Results: The T2WI radiomic-clinical nomogram achieved a favorable prediction performance in the training and validation cohort with an area under ROC curve (AUC) of 0.866 and 0.818, respectively. The DCA showed that the T2WI radiomic-clinical nomogram was better than other models with a greater clinical net benefit.

Conclusion: MR-based radiomics analysis showed the high accuracy in prognostic estimation of EOC patients and could help to predict therapeutic outcome before treatment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753904PMC
http://dx.doi.org/10.1186/s13048-021-00941-7DOI Listing

Publication Analysis

Top Keywords

radiomic-clinical nomogram
12
epithelial ovarian
8
prognosis prediction
8
tumor body
8
validation cohort
8
t1-weighted imaging
8
t2wi radiomic-clinical
8
analysis
5
mr-based radiomics-clinical
4
nomogram
4

Similar Publications

Background: Mucosal healing (MH) is the major therapeutic target for Crohn's disease (CD). As the most commonly involved intestinal segment, small bowel (SB) assessment is crucial for CD patients. Yet, it poses a significant challenge due to its limited accessibility through conventional endoscopic methods.

View Article and Find Full Text PDF

Neural Network and Logistic Regression Models Based on Ultrasound Radiomics and Clinical-Pathological Features to Predict Occult Level II Lymph Node Metastasis in Papillary Thyroid Carcinoma.

Acad Radiol

January 2025

Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China (J-W.F., H.L.); Zhejiang Engineering Research Center of Cognitive Healthcare, Sir Run Run Shaw Hospital,School of Medicine, Zhejiang University, Hangzhou, China (H.L.); College of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou, China (H.L.). Electronic address:

Rationale And Objectives: Papillary thyroid carcinoma (PTC) often metastasizes to lateral cervical lymph nodes, especially in level II. This study aims to develop predictive models to identify level II lymph node metastasis (LNM), guiding selective neck dissection (SND) to minimize unnecessary surgery and morbidity in low-risk patients.

Methods: A retrospective cohort of 313 PTC patients who underwent modified radical neck dissection (MRND) between October 2020 and January 2023 was analyzed.

View Article and Find Full Text PDF
Article Synopsis
  • Many thyroid nodules are found incidentally, and while most are benign, distinguishing malignant ones is challenging, leading to unnecessary anxiety and costs.
  • This study explores using dual-energy computed tomography (DECT) and radiomics to create a nomogram that helps differentiate between malignant and benign thyroid nodules.
  • Results showed the radiomic score and clinical factors like age, normalized iodine concentration, and cyst changes effectively predicted malignant nodules, improving diagnostic accuracy.
View Article and Find Full Text PDF

Predicting first-line VEGFR-TKI resistance and survival in metastatic clear cell renal cell carcinoma using a clinical-radiomic nomogram.

Cancer Imaging

November 2024

Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Panjianyuannanli No.17, Chaoyang District, Beijing, 100021, China.

Background: This study aims to construct predicting models using radiomic and clinical features in predicting first-line vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFR-TKI) early resistance in metastatic clear cell renal cell carcinoma (mccRCC) patients. We also aim to explore the correlation of predicting models with short and long-term survival of mccRCC patients.

Materials And Methods: In this retrospective study, 110 mccRCC patients from 2009 to 2019 were included and assigned into training and test sets.

View Article and Find Full Text PDF
Article Synopsis
  • This study aimed to develop and validate a dual-energy computed tomography-based radiomics model to differentiate between patients with gout flares and those without, addressing a current research gap.
  • It involved analyzing data from 200 patients, including 150 with past gout flares, to extract and evaluate specific radiomic features related to tophi in the foot joints, utilizing advanced statistical methods for model development.
  • The comprehensive model, which combined optimal radiomic features and key clinical factors like disease duration and hypertension, showed strong predictive performance, outperforming individual models in clinical relevance and accuracy.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!